The Safety and Efficacy of Rh-Endostatin (Endostar®) Continuous Intravenous Infusion in Combination With PC/DC Regimens for Untreated Stage IIIB/IV NSCLC
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Endostatin (Primary) ; Carboplatin; Docetaxel; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 24 Oct 2018 New trial record